Fig. 4: Nausea.

a The histograms show the patients’ percentages for the acute (days 1–6), delayed (days 7–8), and overall (days 0–8) phases according to their level of nausea (none, mild, moderate, and severe). b The histograms show nausea levels monitored for 15 days during and following the BEAM/FEAM regimens.